Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
136
Publications avec texte intégral
Open Access
53 %
Mots clés
Expression
Gene therapy
CRISPR/Cas9
Cell culture model
Aging
Centronuclear myopathy
Animals
Myotonic dystrophy
Glucocorticoids
Neuron
Thérapie génique
Brain dysfunction
Acute coronary syndrome
DMPK
Myotonic dystrophy type 1
CRISPRi
Therapy
Acetylcholinesterase deficiency
Antisense oligonucleotides
PacBio
RNA biology
Transgenic mouse
Mouse model
Cytoskeleton
Humans
Gene Therapy
Male
Diaphragm
PCR
Astrocyte
Dystrophie myotonique
Cell penetrating peptide
Glucocorticoid-receptor
MBNL
Acetylcholinesterase knockout mouse
Trinucleotide repeat expansion
Intermediate filament
Myotonic Dystrophy type 1
Transgenic mouse model
RNA splicing
Fibrosis
Exercise
Skeletal muscle
Cardiac muscle
Hypoxia
Heart failure
Maximal force
Dynamin 2
Oligodendrocytes
In vivo
Oligodendrocyte
Glutamate
DMSXL mice
Heart
Brain
Myostatin
Exercice
Dystrophin
Central nervous system
Dilated cardiomyopathy
Endurance training
DM1
Genotype phenotype correlation
Alternative splicing
CMS
Trinucleotide Repeat Expansion
Myotonic Dystrophy Type 1
CTG repeat contractions
Antisense oligonucleotide
Desmin
Motoneuron
Astrocytes
Mouse models
RNA interference
Duchenne muscular dystrophy
Quantitative microdialysis
Knockout
GSK3
GABA
Long read sequencing
Myotonic dystrophy mouse models
CTG repeats
KNOCKOUT MICE
CONGENITAL MYATHENIC SYNDROME
Myotonic Dystrophy
Dystrophie Myotonique
Transcriptomics
AAV
Muscle
Autophagy
Myelin
ARN
BIOLOGIE MOLECULAIRE
Gene editing
ACETYLCHOLINESTERASE
Muscular dystrophy
Mice
Cell model
Glial cells
CTG repeat instability